Balancing Cost-Efficiency with the Need for Domestic Manufacturing
Marcel Botha, CEO of 10XBeta, discusses finding a balance between the need for cost-efficiency and the need to build domestic manufacturing capacity for essential medical devices.
Making M3P Work for Your Pharmacy: A Guide to Streamlining Enrollment and Supporting Patients
M3P will be a financial lifeline for seniors while lowering certain pharmacy costs, but more education and tools are needed to make it successful with pharmacies and their customers.
Pharma Industry Braces for Tariffs
Jim Tananbaum, MD and the Founder and CEO of Foresite Capital, a US-focused health-care investment firm says the sector is ripe for transformation thanks to advances in AI, gene editing and new category-killers in areas like pain management and weight loss. He joined Bloomberg Open Interest to lay out his vision, and how he’s investing as President Trump’s tariff loom large over the pharma industry.
Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition
Johnson & Johnson announced that following the approval of its pending acquisition of Intra-Cellular Therapies, Inc. by Intra-Cellular Therapies’ shareholders on March 27, 2025, Johnson & Johnson intends to complete its acquisition of Intra-Cellular Therapies on or around April 2, 2025.
I cannot believe we’re one week away from #LogiPharmaEurope – the 25th anniversary no less! I’ll be there representingPharmaceutical Commerce- who is a media recording partner at the event – conducting KOL interviews and covering sessions.
I’ll also be moderating a panel on April 9 surrounding how to best approach the implementation of the next generation of cloud-enabled ERP systems, featuring Eme Luth of Envista Holdings Corporation. Thanks to Will Robinson for the opportunity.
Feel free to drop me a line if you’d like to meet! LogiPharma
Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs